临床心身疾病杂志
臨床心身疾病雜誌
림상심신질병잡지
JOURNAL OF CLINICAL PSYCHOSOMATIC DISEASES
2014年
3期
102-104
,共3页
心脏神经症%度洛西汀%谷维素%普萘洛尔%临床疗效%汉密顿焦虑量表%汉密顿抑郁量表
心髒神經癥%度洛西汀%穀維素%普萘洛爾%臨床療效%漢密頓焦慮量錶%漢密頓抑鬱量錶
심장신경증%도락서정%곡유소%보내락이%림상료효%한밀돈초필량표%한밀돈억욱량표
Cardiac neurosis%duloxetine%oryzanol%propranolol%efficacy%HAMA%HAMD
目的:探讨度洛西汀治疗心脏神经症的临床疗效及安全性。方法将92例心脏神经症患者随机分为两组,每组46例,两组均口服谷维素及普萘洛尔治疗,观察组在此基础上联合度洛西汀治疗,观察8周。于治疗前后采用汉密顿焦虑量表、汉密顿抑郁量表评定焦虑抑郁状况,根据症状改善程度判定临床疗效。结果观察组总有效率为93.5%,对照组为78.3%,观察组总有效率显著高于对照组(P<0.05);治疗后两组汉密顿焦虑量表、汉密顿抑郁量表评分均较治疗前显著降低(P<0.01),观察组显著低于对照组(P<0.01);两组不良反应均轻微。结论度洛西汀治疗心脏神经症疗效显著,安全性高。
目的:探討度洛西汀治療心髒神經癥的臨床療效及安全性。方法將92例心髒神經癥患者隨機分為兩組,每組46例,兩組均口服穀維素及普萘洛爾治療,觀察組在此基礎上聯閤度洛西汀治療,觀察8週。于治療前後採用漢密頓焦慮量錶、漢密頓抑鬱量錶評定焦慮抑鬱狀況,根據癥狀改善程度判定臨床療效。結果觀察組總有效率為93.5%,對照組為78.3%,觀察組總有效率顯著高于對照組(P<0.05);治療後兩組漢密頓焦慮量錶、漢密頓抑鬱量錶評分均較治療前顯著降低(P<0.01),觀察組顯著低于對照組(P<0.01);兩組不良反應均輕微。結論度洛西汀治療心髒神經癥療效顯著,安全性高。
목적:탐토도락서정치료심장신경증적림상료효급안전성。방법장92례심장신경증환자수궤분위량조,매조46례,량조균구복곡유소급보내락이치료,관찰조재차기출상연합도락서정치료,관찰8주。우치료전후채용한밀돈초필량표、한밀돈억욱량표평정초필억욱상황,근거증상개선정도판정림상료효。결과관찰조총유효솔위93.5%,대조조위78.3%,관찰조총유효솔현저고우대조조(P<0.05);치료후량조한밀돈초필량표、한밀돈억욱량표평분균교치료전현저강저(P<0.01),관찰조현저저우대조조(P<0.01);량조불량반응균경미。결론도락서정치료심장신경증료효현저,안전성고。
Objective To explore the efficacy and safety of duloxetine in the treatment of cardiac neurosis .Methods Ninety-two patients with cardiac neurosis were randomly divided into 2 groups of 46 ones each , both groups took orally oryzanol and propranolol ,on this basis observation group was plus duloxetine for 8 weeks .Anxiety-depression status was assessed with the Hamilton Anxiety Scale (HAMA) and Hamil-ton Depression Scale (HAMD) before and after treatment ,efficacies were determined according to symp-tom improvement degree .Results Total effective rate was significantly higher in observation than control group (93 .5% vs .78 .3% ,P<0 .05);after treatment the HAMA and HAMD scores of both groups low-ered more significantly compared with pre-treatment (P<0 .01) ,so did that in observation than control group (93 .5% vs .78 .3% ,P<0 .05);adverse reactions of both groups were mild .Conclusion Duloxe-tine has an evident effect and higher safety in the treatment of cardiac neurosis .